In vivo interferon system assessed by 2′-5′ oligoadenylate synthetase activity in chronic hepatitis C virus patients treated with pegylated interferon and ribavirin

SHINDO Michiko; HAMADA Kazushige; MORIKAWA Teruhisa; HARANO Yuichi; NAKAJIMA Tomoaki; OKUNO Tadao

Art

J-GLOBAL ID：200902204876910523 Reference number：09A0003607

In vivo interferon system assessed by 2′-5′ oligoadenylate synthetase activity in chronic hepatitis C virus patients treated with pegylated interferon and ribavirin

ペグインターフェロン及びリバビリンで治療した慢性C型肝炎ウイルス患者において2’-5’オリゴアデニル酸シンテターゼ活性により評価したin vivoインターフェロン系

Publisher site {{ this.onShowPLink() }} Copy service {{ this.onShowCLink("http://jdream3.com/copy/?sid=JGLOBAL&noSystem=1&documentNoArray=09A0003607&COPY=1") }}
Access JDreamⅢ for advanced search and analysis. {{ this.onShowJLink("http://jdream3.com/lp/jglobal/index.html?docNo=09A0003607&from=J-GLOBAL&jstjournalNo=W1284A") }}

Author (6)： , , , , ,
Material：
Volume： 38 Issue： 12 Page： 1213-1220 Publication year： Dec. 2008
JST Material Number： W1284A ISSN： 1386-6346 Document type： Article
Article type：原著論文 Country of issue： Australia (AUS) Language： ENGLISH (EN)

,...
,...

To see more with JDream III (charged). {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=09A0003607&from=J-GLOBAL&jstjournalNo=W1284A") }}

Drug therapy(=pharmacotherapy)for digestive system diseases

Reference (15)：

ALTER, Mj. The prevalence of HCV virus infection in the United States, 1988 through 1994. N Engl J Med. 1999, 341, 556-562
BARTENSCHLAGER, R. Novel insights into HCV virus replication and persistence. Adv Virus Res. 2004, 63, 71-80
MANNS, MP. Peginterferon alfa 2b plus ribavirin compared with interferon alfa 2b plus ribavirin for intial treatment of chronic HCV : a randomized trial. Lancet. 2001, 358, 958-965
FRIED, MW. Combination of peginterferon alfa 2a (40kD) plus ribavirin in patients with chronic HCV infection. N Engl J Med. 2002, 347, 975-982
HADZIYANNIS, SJ. Peginterferon alfa 2a and ribavirin combination therapy in chronic HCV : a randomized study of treatment duration and ribavirin dose. Ann Intern Med. 2004, 140, 346-355

ｍore...

, , , , , , , , ,

Return to Previous Page